Naz Rahman

Stock Analyst at Maxim Group

(0)
# 5088
Out of 5,267 analysts
47
Total ratings
15.38%
Success rate
-45.17%
Average return
21 Stocks
Name Action Price Target Current % Upside Ratings Updated
Viking Therapeutics
Maintains: Buy
120 70
28.85 142.63% 5 Feb 7, 2025
NeuroSense Therapeut...
Downgrades: Hold
n/a
n/a n/a 2 Dec 16, 2024
Cingulate
Upgrades: Buy
n/a
n/a n/a 4 Nov 20, 2024
Palisade Bio
Maintains: Buy
23 8
0.81 887.65% 7 Nov 13, 2024
Silexion Therapeutic...
Initiates Coverage On: Buy
9
1.07 741.12% 1 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Oct 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3
0.77 289.61% 1 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Mar 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 4
0.31 1190.32% 2 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
0.1 3900% 1 Dec 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Nov 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
5
1.29 287.6% 1 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 20
3.28 509.76% 2 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 May 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
3.07 95.44% 1 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Dec 7, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
n/a n/a 1 Mar 31, 2021